Monitoring NOACs: heresy or care refinement?

8 July 2016 (14:05 - 14:25)

Organised by:

Slides

Sign in to view the resources

About the speaker

Doctor Marcel M Levi

Amsterdam (Netherlands (The))

5 More presentations in this session

Presentation thumbnail

Thrombosis revisited: the role of platelets and thrombin in venous and arterial thrombosis.

Professor A. Siegbahn (Uppsala, SE)

Presentation thumbnail

Anticoagulation therapy in 2016 and beyond: from theory to practice.

Doctor J. Weitz (Hamilton, CA)

Presentation thumbnail

NOACs for treatment of venous thromboembolism: where are we, and where are we going?

Professor W. Ageno (Padova, IT)

Presentation thumbnail

NOACs in atrial fibrillation and coronary heart disease: where are we and where are we going?

Professor R. De Caterina (Pisa, IT)

Presentation thumbnail

Reversal of non-vitamin K antagonist oral anticoagulants: true need or perception in search of solutions.

Doctor J. Van Ryn (Biberach, DE)

Access the full session

Session thumbnail

Anticoagulants in cardiovascular disease – from basics to translation

The Event

Frontiers in CardioVascular Biology 2016

8 July 2016 14:05 CET

You may be interested in

Congress Presentation

One year after the 2021 EHRA practical guide on NOACs: main points and new aspects.

3 April 2022

Congress Presentation

Edoxaban monitoring strategy using chromogenic anti-Xa assays among patients with atrial fibrillation

3 April 2025

Webinar

Are NOACs already outdated? New trends in anticoagulation therapy

12 December 2022

Congress Presentation

Use of Non-vitamin K antagonist Oral Anticoagulants in a real-world setting: a community pharmacy-based study.

31 August 2019

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources